Desk›Healthcare› Decipher Labs Ltd
Decipher Labs Ltd
BSE 524752 · NSE DECIPHER · ISIN INE643N01012 · Group X · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹5.65
+0.00%
BSE close, 28 August 2026
₹5.71 cr
1.0 cr shares · Micro cap
₹4.64 cr
as published
-14.9× · 0.65×
EPS ₹-0.38 · BV ₹8.69
1.14 / -0.25
₹ cr, as filed
13
4 selected · 31%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -49.6% |
|---|---|
| Against 52-week low | +13.0% |
| Day change | +0.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-0.38 |
|---|---|
| Price / earnings | -14.87× |
| Price / book | 0.65× |
| Book value — derived, price ÷ P/B | ₹8.69 |
| Return on equity | -4.37% |
| Operating margin | -75.51% |
| Net margin | -80.61% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -4.37%
- ROE as published
- -4.37%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 0.10 | -0.08 | -0.08 | -75.51% | -80.61% |
| Mar-26 · Q | 0.07 | -0.17 | -0.17 | -252.24% | -258.21% |
| FY25-26 | 1.14 | -0.25 | -0.24 | -19.38% | -21.76% |
Quarter on quarter
- Revenue, quarter on quarter
- +42.9%
- Net profit, quarter on quarter
- +52.9%
- Operating margin, quarter on quarter
- +17,673 bps
Disclosure profile 13 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Results | 2 |
| Board Outcome | 1 |
| Change in Directorate | 1 |
| Selected sub-total | 4 |
| Procedural | |
| AGM / EGM | 4 |
| General | 2 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Trading Window | 1 |
| Procedural sub-total | 9 |
| Total | 13 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
13 filings · 4 selected · busiest 2026-08-13
Filing rhythm · the twelve most recent
2026-08-132026-09-30
SelectedProcedural
Filings
13 in the window · 2 earlier on record
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and Scrutinizer's Report for 40th Annual General Meeting held on 30th September, 2026 at 11:00 AM.
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome and Proceedings of 40th Annual General Meeting held on 30th September, 2026 at 11:00 AM.
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Closure of Trading Window
Closure of trading window for the period ending on 30.09.2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
9 September 2026 ·
Newspaper Advertisement For AGM Notice For The Financial Year 2025-26.
Newspaper Advertisement for the Annual General Meeting to be held for the FY_2025-26.
Company Update / General View filing →
-
8 September 2026 ·
Intimation Of Book Closure And Cut Off Date For Annual General Meeting
Intimation of Book Closure date and Cut Off Date for Annual General Meeting scheduled to be held on 30th September, 2026.
AGM/EGM / AGM View filing →
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
40th Annual Report for the Financial Year 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
8 September 2026 ·
Notice Of 40Th Annual General Meeting For The Financial Year 2025-26 Under Regulation 34 Of SEBI (LODR) Regulation 2015.
Notice of the 40th Annual General Meting for the Financial Year 2025-26 under regulation 34 of SEBI (LODR), Regulations 2015.
AGM/EGM / AGM View filing →
-
14 August 2026 ·
Announcements Under Regulation 30 Of SEBI (LODR), Regulations, 2015.
Announcement under Regulation 30 of SEBI (Listng Obligations and Disclosure Requirement), Regulations, 2015.
Company Update / General View filing →
-
13 August 2026 ·
Revised Un-Audited Financial Results For The Quarter Ended 30.06.2026.
Revised Un-audited Financial Results for the quarter ended 30.06.2026.
Result / Financial Results View filing →
-
13 August 2026 ·
Change in Directorate
Appointment of Mr. Bhupendralal Waghray as an Additional Director (Independent Category) of the company for a period of Five (5) years w.e.f. 13.08.2026 subject to approval of shareholders.
Company Update / Change in Directorate View filing →
-
13 August 2026 ·
Financial Results For The Quarter Ended 30.06.2026.
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.
Result / Financial Results View filing →
-
13 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting held on 13th August, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
6 August 2026 ·
Board Meeting Intimation for Meeting Scheduled To Be Held On 13Th August, 2026.
Decipher Labs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-audited financial results ....
Board Meeting / Board Meeting View filing →
RSS feed for Decipher Labs Ltd · the 50 most recent filings